Solving the mystery of progression: the key to new treatments for progressive MS

The International Progressive MS Alliance exists to accelerate the development of effective treatments for people with progressive forms of MS to improve quality of life worldwide. It is an unprecedented global collaboration of MS organisations, researchers, health professionals, the pharmaceutical industry, companies, trusts, foundations, donors and people affected by progressive MS, working together to address the unmet needs of people with progressive MS ─ rallying the global community to find solutions. Our promise is more than hope, it is progress.

The Alliance was established in 2012, by six founding members: MSIF, and the MS societies of Canada, Italy, the Netherlands, the UK and the USA, who made a joint commitment to speed up the development of treatment for progressive MS by removing scientific and technology barriers.

The Alliance now has 19 member organisations who, between them, have many years’ experience of MS research and have funded significant developments in research, disease-modifying therapies and symptom treatments.

We're always looking for member organisations to add translated subtitles to video resources, so they can be accessible to people in different countries around the world. Not a member? If we don't have a member that speaks your language and you would like to add subtitles to this resource, we'd love to hear from you to discuss options and explore what's possible!